IL17A and hepatocellular carcinoma: IL-17 is highly expressed in a subset of patients with prostate, colorectal, gastric, breast, lung, and hepatocellular carcinomas, and some studies have shown that its expression level is positively correlated with tumor progression; however, some studies have shown that IL-17 is beneficial for human survival (14, 15).